Fanghua Gong

First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients

Jinzi J. Wu, Zhicheng Zhang, Hongyi Chen, 2020, Medicine.

First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients

Li Wang, Jinzi J. Wu, Zhicheng Zhang, 2020, medRxiv.